Literature DB >> 1991159

Erythropoietin.

S B Krantz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991159

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  186 in total

1.  Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.

Authors:  Ke Liang; Francisco J Esteva; Constance Albarracin; Katherine Stemke-Hale; Yang Lu; Giampaolo Bianchini; Ching-Yi Yang; Yong Li; Xinqun Li; Chun-Te Chen; Gordon B Mills; Gabriel N Hortobagyi; John Mendelsohn; Mien-Chie Hung; Zhen Fan
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

Review 2.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

3.  Effect of intraperitoneal erythropoietin on the degree of mucosal damage of left colon flaps in rats.

Authors:  Erdal Turk; Irfan Karaca; Aytac Karkiner; Hüseyin Evciler; Ragip Ortac; Z Gunyuz Temir; Basak Ucan; Derya Yayla
Journal:  Pediatr Surg Int       Date:  2010-02-24       Impact factor: 1.827

4.  Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene.

Authors:  Mark A Hall; Nicholas J Slater; C Glenn Begley; Jessica M Salmon; Leonie J Van Stekelenburg; Matthew P McCormack; Stephen M Jane; David J Curtis
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia.

Authors:  David Cervi; Yuval Shaked; Mehran Haeri; Tatiana Usenko; Christina R Lee; Jody J Haigh; Andras Nagy; Robert S Kerbel; Eitan Yefenof; Yaacov Ben-David
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  Functional conservation of erythropoietin signaling in zebrafish.

Authors:  Noëlle Paffett-Lugassy; Nelson Hsia; Paula G Fraenkel; Barry Paw; Irene Leshinsky; Bruce Barut; Nathan Bahary; Jaime Caro; Robert Handin; Leonard I Zon
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

8.  Increased erythropoietin response to venesection in erythrocytosic renal transplant patients.

Authors:  O Oymak; H Demiroğlu; T Akpolat; Y Erdem; U Yasavul; C Turgan; S Cağlar; S Dündar; S Kirazli
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

9.  A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.

Authors:  Concetta G A Marfella; Nils Henninger; Scott E LeBlanc; Namrata Krishnan; David S Garlick; Lawrence B Holzman; Anthony N Imbalzano
Journal:  Kidney Blood Press Res       Date:  2009-01-14       Impact factor: 2.687

10.  Localization of erythropoietin in and around growing cartilage.

Authors:  Ward De Spiegelaere; Pieter Cornillie; Wim Van den Broeck
Journal:  Mol Cell Biochem       Date:  2009-11-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.